144
Participants
Start Date
December 5, 2024
Primary Completion Date
October 30, 2025
Study Completion Date
October 30, 2025
PG-102
"* Participants will receive PG-102 by subcutaneous (SC) injection.~* Other Names: MG12"
Placebo
Participants will receive placebo by SC injection
The Catholic University of KOREA, Bucheon St.Mary's Hostital, Bucheon-si
Yeungnam University Medical Center, Daegu
Daejeon Eul Ji Medical Center, Eul Ji University, Daejeon
Seoul National University Bundang Hospital, Seongnam
Kangbuk Samsung Hospital, Samsung Medical Center, Seoul
KOREA University Anam Hospital, Seoul
KOREA University Asan Hospital, Seoul
Kyung Hee University Hospital at Gangdong, Seoul
Kyung Hee University, Medical Center, Seoul
Nowon Eul Ji Medical Center, Eul Ji University, Seoul
Samsung Medical Center, Seoul
Severance Hostital, Seoul
The Catholic University of KOREA, Seoul St.Mary's Hostital, Seoul
The Catholic University of KOREA, Yeouido St.Mary's Hostital in Korea, Seoul
ProGen. Co., Ltd.
OTHER